BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Healthcare

FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns

Thermal burns are typically caused by direct contact with an external heat source such as steam, scalding water, hot surfaces or fire. "Serious burns can ...

June 16, 2021 | News

AAS : Next Steps For New Alzheimer's Treatment

Additionally, the FDA appropriately took into account the vast unmet need of the Alzheimer's community. Aduhelm is certainly not a cure, but at long last i...

June 14, 2021 | News

Viraleze registered for sale in Covid-ravaged India

The announcement came as the world's second most populous country battles a devastating second wave of COVID-19 infections, with over 29 million cases and ...

June 14, 2021 | News

Japan takes step ahead to treat hereditary deafness

Researchers at Juntendo University in Japan report in the journal Human Molecular Genetics that a stem-cell technique may be used to develop a tr...

June 11, 2021 | News

VinBrain and FIT Utilizing AI in Tuberculosis Screening in Veitnam

Tuberculosis is the leading cause of deaths worldwide from an infectious disease, second only to COVID-19. Vietnam ranks 11th among t...

June 10, 2021 | News

FDA’s Decision to Approve New Treatment for Alzheimer’s Disease

This approval is significant in many ways. Aduhelm is the first novel therapy approved for Alzheimer’s disease since 2003. Perhaps more significantly...

June 09, 2021 | News | By Dr. Patrizia Cavazzoni, Director, FDA Center for Drug Evaluation and Research

“700,000 people in USA are living with primary brain tumour”

Brain tumors originate from the brain itself, or it can be secondary extension from other parts. Brain tumors in India comes to 5-10 in 100,000 popul...

June 08, 2021 | Opinion

Cigna Study Shows Uncertainty about the Future Continues to be the Leading Cause of Stress

Cigna Hong Kong today released the Hong Kong findings of the latest edition of its Cigna COVID-19 Global Impact Study. As part of Cigna's an...

June 08, 2021 | Analysis

Ascletis Received China IND Approval for Chronic hepatitis B

Ascletis Pharma Inc. (HKEX: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND...

June 07, 2021 | News

Arctic Vision Announces the Treatment of Dry Eye Disease

iTEAR®100 is an FDA-cleared external neurostimulation device that increases acute tear production. Arctic Vision, a clinical stage biotech company foc...

June 07, 2021 | News

Singapore/ US based TurtleTree ready to commercialize Human Lactoferrin as first major product

Milk is a very complex evolutionary fluid with millions of different molecules in it. While it will take several years before cell-based whole milk passes ...

June 05, 2021 | News

China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection

By leveraging the proprietary technology platform built for drug discovery and screening, MicuRx R&D team discovered the next-generation oxazolidinone ...

June 04, 2021 | News

Molecules in Saliva May Hold the Key to Tracking Improvements in Autism

According to a recently published study, specific RNA molecules in saliva were found to be strongly associated with autistic behaviors in older individuals...

June 04, 2021 | News

MyLab’s in India starts shipping COVID-19 self-test kit, CoviSelfTM

It is the first test kit for COVID-19 that can be self-administered by citizens at home, in India. This indigenous test kit will be distributed through to ...

June 03, 2021 | News

Stay Connected